Industries > Pharma > Biologics Market Report 2022-2032
Biologics Market Report 2022-2032
Forecasts by Product Type (Monoclonal Antibodies, Vaccines, Protein Therapeutics Fusion Proteins and Regenerative Medicine), by Application (Oncology, Autoimmune Disorder, Infectious Diseases, Cardiovascular Disorders, Hematological Disorders, Others), by Manufacturing (Outsourced, In-house) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios
SKU: PHA1177
Categories: Biotechnology, Pharma, Therapeutic Drugs
Tags: PHA1009, PHA1177, PHA1186, PHA1266
The Biologics Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Active R&D and Focus on Clinical Trials is Boosting the Biologics Market Growth
Active R&D and focus on clinical trials is driving the global biologics market growth. These R&D operations have resulted in increased success rates in biologic clinical studies. Industry leaders in the biologics market do R&D as they strive to produce market innovations in the form of effective and innovative biologics. Companies in the biologics sector have huge profit margins because of the high pricing of biologics and their efficacy. For decades, pharmaceutical corporations have focused on small compounds, but the rate of discovery in that sector has slowed drastically, resulting in a move toward biologics. Biologics therapy, which is roughly 20 times more expensive than small molecules, is predicted to create a profit margin of about 40%-45% in the future.
Logistical and Administrative Challenges
Governments and regulatory agencies play important roles in the biologics sector. Regulatory bodies maintain regulatory procedures for the development of new biologics markets for both existing and novel pharmaceuticals. Over the last decade, drug researchers have faced an increasing pushback in major markets for clinical studies of innovative biologics, which has hindered the launch of novel treatments for rare diseases. Strategic measures have been taken in these large markets, such as the United States and the European Union, to strengthen and liberalise regulatory regulations, hence simplifying clinical trial design. However, an increase in government spending for drug-related healthcare programmes is critical to industry success.
What Questions Should You Ask before Buying a Market Research Report?
• How is the biologics market evolving?
• What is driving and restraining the biologics market?
• How will each biologics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each biologics submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading biologics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the biologics projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What is the implication of biologics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the biologics market?
• Where is the biologics market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the biologics market today, and over the next 10 years:
• Our 475-page report provides 308 tables and 320 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analysis of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors
This report tells you TODAY how the biologics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Delivers exclusive COVID-19 variations economic data specific to your market.
To access the data contained in this document please email contactus@visiongain.com
Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising biologics prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Product Type
• Monoclonal Antibodies
• Vaccines
• Protein Therapeutics
• Fusion Proteins
• Regenerative Medicine
Application
• Oncology
• Autoimmune Disorder
• Infectious Diseases
• Cardiovascular Disorders
• Hematological Disorders
• Others
Manufacturing
• Outsourced
• In-house
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles for some of the leading companies in the Biologics Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• AbbVie Inc.
• Amgen Inc.
• Biogen
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc.
• Johnson & Johnson Services, Inc.
• Merck KGaA
• Novartis AG
• NuVasive, Inc.
• Novo Holdings A/S (Novo Nordisk A/S)
• Organogenesis Holdings Inc.
• ORTHOFIX INTERNATIONAL N.V.
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Company Limited
Overall world revenue for Biologics Market, 2022 to 2032 in terms of value the market will surpass US$382.85 billion in 2022, our work calculates. We predict strong revenue growth through 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Biologics Market, 2022 to 2032 Market report helps you?
In summary, our 470+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Biologics Market, 2022 to 2032 Market, with forecasts for product type, application, and manufacturing each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2032 for 5 regional and 22 key national markets – See forecasts for the Biologics Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 18 of the major companies involved in the Biologics Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our new report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Biologics Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Biologics Market Report 2022-2032: Forecasts by Product Type (Monoclonal Antibodies, Vaccines, Protein Therapeutics Fusion Proteins and Regenerative Medicine), by Application (Oncology, Autoimmune Disorder, Infectious Diseases, Cardiovascular Disorders, Hematological Disorders, Others), by Manufacturing (Outsourced, In-house) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview
1.1 Introduction to Biologics Market
1.2 Biologics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Advancements in Biomedical Science
3.1.2 Increasing Funding for the Development of Novel Biologic Drugs
3.1.3 Several Drugs Going Off Patents
3.2 Restraints
3.2.1 High Stringency and Low Turnover for Clinical Trials
3.2.2 Development of Biosimilars will Reduce the Demand for Biological Drugs
3.3 Opportunities
3.3.1 Biologic Therapies are Becoming Relevant in a Greater Number of Disease Areas
3.4 Challenges
3.4.1 Complexity in Development of Biologics
3.5 SWOT Analysis
3.5.1 Strengths
3.5.1.1 Rising Need for Effective biologics Absorption and Convenient Self-Administration Emphasizes the Importance of the R&D Investment
3.5.2 Weaknesses
3.5.2.1 Financial Loss Due To Innovative Biologics Failure Has Been a Perennial Problem
3.5.3 Opportunities
3.5.3.1 Strong pipeline products and huge number of ongoing clinical trials are providing market growth opportunity.
3.5.3.2 Application of Nanotechnology in future
3.5.4 Threats
3.5.4.1 Small Molecules
3.6 Porter’s Five Forces Analysis
3.6.1 Bargaining Power of Supplier: High
3.6.2 Bargaining Power of Buyers: Moderate
3.6.3 Competitive Rivalry: High
3.6.4 Threat of New Entrants: Moderate
3.6.5 Threat of Substitutes: Low
3.7 PEST Analysis
3.7.1 Political Factors Impacting Biologics Market
3.7.2 Economic Factors Impacting Biologics Market
3.7.3 Social Factors Impacting Biologics Market
3.7.4 Technological Factors Impacting Biologics Market
4 Biologics Market by Product Type Forecast, 2022-2032
4.1 Monoclonal Antibodies Segment Market Forecast, 2022-2032
4.1.1 Monoclonal Antibodies: Holds Largest Market Share
4.1.2 Recovery Scenarios (V, U, W, L)
4.2 Vaccine Segment Market Forecast, 2022-2032
4.2.1 Vaccine Manufacturing Remains Concentrated, With Four Large Manufacturers
4.2.2 Recovery Scenarios (V, U, W, L)
4.3 Protein Therapeutics Segment Market Forecast, 2022-2032
4.3.1 Increased public knowledge of the benefits of protein therapies
4.3.2 Recovery Scenarios (V, U, W, L)
4.4 Regenerative Medicines Segment Market Forecast, 2022-2032
4.4.1 Government policies favouring Regenerative Medicines
4.4.2 Recovery Scenarios (V, U, W, L)
4.5 Fusion Proteins Segment Market Forecast, 2022-2032
4.5.1 Rising prevalence of diabetes expected to boost demand of fusion proteins
4.5.2 Recovery Scenarios (V, U, W, L)
5 Biologics Market by Application Forecast, 2022-2032
5.1 Oncology Segment Market Forecast, 2022-2032
5.1.1 Biological cancer therapy aims to train the immune system to recognise and kill cancer cells
5.1.2 Recovery Scenarios (V, U, W, L)
5.2 Autoimmune Diseases Segment Market Forecast, 2022-2032
5.2.1 Increasing Research and Development in this segment
5.2.2 Recovery Scenarios (V, U, W, L)
5.3 Infectious Diseases Therapeutics Segment Market Forecast, 2022-2032
5.3.1 Possible alternative to oral and parenteral routes of administration
5.3.2 Recovery Scenarios (V, U, W, L)
5.4 Cardiovascular Diseases Segment Market Forecast, 2022-2032
5.4.1 Cardiovascular Disorders is becoming the top cause of death worldwide
5.4.2 Recovery Scenarios (V, U, W, L)
5.5 Haematological Disorders Segment Market Forecast, 2022-2032
5.5.1 Blood disorders became a worldwide health issue
5.5.2 Recovery Scenarios (V, U, W, L)
5.6 Others Segment Market Forecast, 2022-2032
5.6.1 Adoption Haematological Disorders Technologies is expected to boost the Others Segment Growth
5.6.2 Recovery Scenarios (V, U, W, L)
6 Biologics Market by Manufacturing Forecast, 2022-2032
6.1 In-house Segment Market Forecast, 2022-2032
6.1.1 In-house holds largest Revenue market share
6.1.2 Recovery Scenarios (V, U, W, L)
6.2 Outsourced Segment Market Forecast, 2022-2032
6.2.1 Ease of use of Topical drug delivery to boost the outsourced market
6.2.2 Recovery Scenarios (V, U, W, L)
7 Global Biologics Market Forecast, 2022-2032
7.1 Global Biologics Market by Region Forecast 2022-2032
7.2 Recovery Scenarios (V, U, W, L)
8 North America Biologics Market, 2022-2032
8.1 Largest share acquired by North America in Global Biologics Market
8.2 North America Biologics Market by Country, Forecast 2022-2032
8.3 North America Biologics Market Forecast by Product Type
8.3.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Product Type, 2022-2032
8.4 North America Biologics Market Forecast by Application
8.4.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Application, 2022-2032
8.5 North America Biologics Market Forecast by Manufacturing
8.5.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Manufacturing, 2022-2032
8.6 U.S. Biologics Market Forecast, 2022-2032
8.6.1 Growing public and private funding for research studies in this region
8.6.2 Budget request for Pandemic preparedness
8.6.3 Recovery Scenarios (V, U, W, L): U.S. Biologics Market Forecast, 2022-2032
8.7 Canada Biologics Market Forecast, 2022-2032
8.7.1 Growing Prevalence of Psoriasis and Related Research and Development across the Region
8.7.2 Biologics represent a large segment of drug spending in Canada
8.7.3 Recovery Scenarios (V, U, W, L): Canada Biologics Market Forecast, 2022-2032
9 Europe Biologics Market, 2022-2032
9.1 Launch of Advanced Biologics across the Region
9.2 Europe Biologics Market by Country, Forecast 2022-2032
9.3 Europe Biologics Market Forecast by Product Type
9.3.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Product Type, 2022-2032
9.4 Europe Biologics Market Forecast by Application
9.4.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Application, 2022-2032
9.5 Europe Biologics Market Forecast by Manufacturing
9.5.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Manufacturing, 2022-2032
9.6 Germany Biologics Market Forecast, 2022-2032
9.6.1 German government support market player for product development
9.6.2 Recovery Scenarios (V, U, W, L): Germany Biologics Market Forecast, 2022-2032
9.7 U.K. Biologics Market Forecast, 2022-2032
9.7.1 Increase in prevalence of diabetes and skin conditions
9.7.2 Recovery Scenarios (V, U, W, L): U.K. Biologics Market Forecast, 2022-2032
9.8 France Biologics Market Forecast, 2022-2032
9.8.1 Growing cancer prevalence and French government cancer control strategy
9.8.2 Recovery Scenarios (V, U, W, L): France Biologics Market Forecast, 2022-2032
9.9 Italy Biologics Market Forecast, 2022-2032
9.9.1 Rising prevalence of cancer
9.9.2 Recovery Scenarios (V, U, W, L): Italy Biologics Market Forecast, 2022-2032
9.10 Spain Biologics Market Forecast, 2022-2032
9.10.1 Growing burden of Infectious diseases
9.10.2 Recovery Scenarios (V, U, W, L): Spain Biologics Market Forecast, 2022-2032
9.11 Russia Biologics Market Forecast, 2022-2032
9.11.1 Major leap forward in terms of Digitalization
9.11.2 Recovery Scenarios (V, U, W, L): Russia Biologics Market Forecast, 2022-2032
9.12 Rest of Europe Biologics Market Forecast, 2022-2032
9.12.1 Rising Adoption of Advanced Biologics
9.12.2 Recovery Scenarios (V, U, W, L): Rest of Europe Biologics Market Forecast, 2022-2032
10 Asia Pacific Biologics Market, 2022-2032
10.1 Biologics APAC will emerge as the fastest growing regional market for biologics market R&D and production
10.2 Asia Pacific Biologics Market by Country, Forecast 2022-2032
10.3 Asia Pacific Biologics Market Forecast by Product Type
10.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Product Type, 2022-2032
10.4 Asia Pacific Biologics Market Forecast by Application
10.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Application, 2022-2032
10.5 Asia Pacific Biologics Market Forecast by Manufacturing
10.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032
10.6 Japan Biologics Market Forecast, 2022-2032
10.6.1 Major market players investing on R&D
10.6.2 Recovery Scenarios (V, U, W, L): Japan Biologics Market Forecast, 2022-2032
10.7 China Biologics Market Forecast, 2022-2032
10.7.1 Rapid growth of Domestic mAb pipeline and regulatory reform is creating business opportunities for Biologics CDMO’s in China
10.7.2 Recovery Scenarios (V, U, W, L): China Biologics Market Forecast, 2022-2032
10.8 India Biologics Market Forecast, 2022-2032
10.8.1 India Biologics market currently is dominated by Simple Biologics
10.8.2 Recovery Scenarios (V, U, W, L): India Biologics Market Forecast, 2022-2032
10.9 Australia Biologics Market Forecast, 2022-2032
10.9.1 Growing capital investment by the market player
10.9.2 Recovery Scenarios (V, U, W, L): Australia Biologics Market Forecast, 2022-2032
10.10 South Korea Biologics Market Forecast, 2022-2032
10.10.1 Increasing prevalence of Cancer in South Korea
10.10.2 Recovery Scenarios (V, U, W, L): South Korea Biologics Market Forecast, 2022-2032
10.11 Rest of Asia Pacific Biologics Market Forecast, 2022-2032
10.11.1 Rising Disposable Income in this region
10.11.2 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Biologics Market Forecast, 2022-2032
11 Latin America Biologics Market, 2022-2032
11.1 Latin America Biologics Market expected to grow at lucrative CAGR
11.2 Latin America Biologics Market by Country, Forecast 2022-2032
11.3 Latin America Biologics Market Forecast by Product Type
11.3.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Product Type, 2022-2032
11.4 Latin America Biologics Market Forecast by Application
11.4.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Application, 2022-2032
11.5 Latin America Biologics Market Forecast by Manufacturing
11.5.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Manufacturing, 2022-2032
11.6 Brazil Biologics Market Forecast, 2022-2032
11.6.1 High Potential Manufacturing Environment
11.6.2 Recovery Scenarios (V, U, W, L): Brazil Biologics Market Forecast, 2022-2032
11.7 Mexico Biologics Market Forecast, 2022-2032
11.7.1 Lower Manufacturing Cost in Mexico
11.7.2 Recovery Scenarios (V, U, W, L): Mexico Biologics Market Forecast, 2022-2032
11.8 Rest of Latin America Biologics Market Forecast, 2022-2032
11.8.1 Developing Healthcare Infrastructure in this region
11.8.2 Recovery Scenarios (V, U, W, L): Rest of Latin America Biologics Market Forecast, 2022-2032
12 MEA Biologics Market, 2022-2032
12.1 Increasing occurrence of Cancer in this region
12.2 MEA Biologics Market by Country, Forecast 2022-2032
12.3 MEA Biologics Market Forecast by Product Type
12.3.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Product Type, 2022-2032
12.4 MEA Biologics Market Forecast by Application
12.4.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Application, 2022-2032
12.5 MEA Biologics Market Forecast by Manufacturing
12.5.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Manufacturing, 2022-2032
12.6 GCC Biologics Market Forecast, 2022-2032
12.6.1 Presence of Hug Growth Opportunities
12.6.2 Recovery Scenarios (V, U, W, L): GCC Biologics Market Forecast, 2022-2032
12.7 South Africa Biologics Market Forecast, 2022-2032
12.7.1 Rapidly increasing infectious diseases in this South Africa
12.7.2 Recovery Scenarios (V, U, W, L): South Africa Biologics Market Forecast, 2022-2032
12.8 Rest of MEA Biologics Market Forecast, 2022-2032
12.8.1 Cancer is one of the main reason of Death causes in Rest of MEA
12.8.2 Recovery Scenarios (V, U, W, L): Rest of MEA Biologics Market Forecast, 2022-2032
13 Company Profiles
13.1 Company Share Analysis
13.2 Biologics Market Recent Developments
13.3 Johnson & Johnson Services, Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2021
13.3.3.2 Regional Revenue/Market Shares, 2021
13.3.3.3 Segmental Revenue/Market Shares, 2021
13.3.4 Product Benchmarking
13.3.5 Recent Developments
13.4 Merck KGaA
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2021
13.4.3.2 Regional Revenue/Market Shares, 2021
13.4.3.3 Segmental Revenue/Market Shares, 2021
13.4.4 Product Benchmarking
13.4.5 Recent Developments
13.5 GlaxoSmithKline plc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2017-2021
13.5.3.2 Regional Revenue/Market Shares, 2021
13.5.3.3 Segmental Revenue/Market Shares, 2021
13.5.4 Product Benchmarking
13.5.5 Recent Developments
13.6 Novartis AG
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2017-2021
13.6.3.2 Regional Revenue/Market Shares, 2021
13.6.3.3 Segmental Revenue/Market Shares, 2021
13.6.4 Product Benchmarking
13.6.5 Recent Developments
13.7 F. Hoffmann-La Roche Ltd
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2017-2021
13.7.3.2 Segmental Revenue/Market Shares, 2021
13.7.3.3 Regional Revenue/Market Shares, 2020
13.7.4 Product Benchmarking
13.7.5 Recent Developments
13.8 Pfizer Inc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2017-2021
13.8.3.2 Regional Revenue/Market Shares, 2021
13.8.3.3 Segmental Revenue/Market Shares, 2021
13.8.4 Product Benchmarking
13.8.5 Recent Developments
13.9 Sanofi
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2017-2021
13.9.3.2 Regional Revenue/Market Shares, 2021
13.9.3.3 Segmental Revenue/Market Shares, 2021
13.9.4 Product Benchmarking
13.9.5 Recent Developments
13.10 Novo Holdings A/S (Novo Nordisk A/S)
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2017-2021
13.10.3.2 Regional Revenue/Market Shares, 2020
13.10.3.3 Segmental Revenue/Market Shares, 2020
13.10.4 Product Benchmarking
13.10.5 Recent Developments
13.11 Takeda Pharmaceutical Company Limited
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2017-2021
13.11.3.2 Regional Revenue/Market Shares, 2020
13.11.3.3 Segmental Revenue/Market Shares, 2020
13.11.4 Product Benchmarking
13.12 Eli Lilly and Company
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2017-2021
13.12.3.2 Regional Revenue/Market Shares, 2020
13.12.4 Product Benchmarking
13.12.5 Recent Developments
13.13 Amgen Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2017-2021
13.13.3.2 Regional Revenue Shares, 2021
13.13.3.3 Segment Revenue Shares, 2021
13.13.4 Product Benchmarking
13.13.5 Recent Developments
13.14 Bristol-Myers Squibb Company
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2017-2021
13.14.3.2 Regional Revenue Shares, 2021
13.14.4 Product Benchmarking
13.14.5 Recent Developments
13.15 Biogen
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis
13.15.3.1 Net Revenue, 2017-2021
13.15.3.2 Regional Revenue Shares, 2021
13.15.4 Product Benchmarking
13.15.5 Recent Developments
13.16 NuVasive, Inc.
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Financial Analysis
13.16.3.1 Net Revenue, 2017-2021
13.16.3.2 Regional Revenue Shares, 2021
13.16.3.3 Segment Revenue Shares, 2021
13.16.4 Product Benchmarking
13.17 ORTHOFIX INTERNATIONAL N.V.
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Financial Analysis
13.17.3.1 Net Revenue, 2017-2021
13.17.3.2 Regional Revenue Shares, 2021
13.17.3.3 Segment Revenue Shares, 2020
13.17.4 Product Benchmarking
13.18 Organogenesis Holdings Inc.
13.18.1 Company Snapshot
13.18.2 Company Overview
13.18.3 Financial Analysis
13.18.3.1 Net Revenue, 2018-2021
13.18.3.2 Segment Revenue Shares, 2021
13.18.4 Product Benchmarking
13.19 AbbVie Inc.
13.19.1 Company Snapshot
13.19.2 Company Overview
13.19.3 Financial Analysis
13.19.3.1 Net Revenue, 2017-2021
13.19.3.2 Regional Revenue Shares, 2021
13.19.3.3 Segment Revenue Shares, 2021
13.19.4 Product Benchmarking
13.19.5 Recent Developments
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
List of Tables
Table 1 Global Biologics Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 Global Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 3 Global Biologics examples of US FDA-approved monoclonal antibody present in the market, CAGR%)
Table 4 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 5 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 6 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 7 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 8 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 9 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 10 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 11 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 12 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 13 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 14 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 15 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 18 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 19 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 20 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 25 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 30 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 31 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 32 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 33 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 34 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 35 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 36 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global Biologics Market for Autoimmune diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 39 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 40 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 41 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 42 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 43 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 44 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 45 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 46 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 47 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 48 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 49 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 50 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 51 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 56 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 1 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Global Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 60 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 61 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 62 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 63 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 64 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 65 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 66 Global Biologics Market for outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 67 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 68 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 69 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 70 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 71 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 72 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 73 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 74 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 75 North America Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 76 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 77 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 78 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 79 North America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 80 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 81 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 82 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 84 North America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 85 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 86 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 87 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 88 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 89 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 90 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 91 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 92 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 93 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 94 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 95 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 96 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 97 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 101 Europe Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 102 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 103 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 104 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 105 Europe Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 106 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 107 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 108 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 109 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 110 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 111 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 112 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 113 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 114 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 115 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 116 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 117 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 118 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 119 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 120 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 121 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 122 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 123 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 124 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 125 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 126 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 127 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 128 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 129 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 130 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 131 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 132 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 133 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 134 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 135 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 136 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 137 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 138 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 139 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 140 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 141 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 142 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 143 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 144 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 145 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 146 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 147 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 148 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 149 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 150 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 151 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 152 Asia Pacific Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 153 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 154 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Asia Pacific Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 158 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 159 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Asia Pacific Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 162 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 163 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 164 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 165 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 166 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 167 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 168 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 169 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 170 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 171 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 172 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 173 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 174 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 175 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 176 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 177 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 178 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 179 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 180 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 181 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 182 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 183 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 184 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 185 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 186 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 187 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 188 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 189 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 190 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 191 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 192 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 193 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 194 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 195 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 196 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 197 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 198 Latin America Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 199 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 200 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 201 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 202 Latin America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 203 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 204 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 205 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 206 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 207 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 208 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 209 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 210 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 211 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 212 Latin America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 213 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 214 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 215 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 216 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 217 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 218 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 219 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 220 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 221 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 222 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 223 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 224 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 225 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 226 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 227 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 228 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 229 MEA Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 230 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 231 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 232 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 233 MEA Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 234 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 235 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 236 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 237 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 238 MEA Biologics Market Forecast by application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 239 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 240 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 241 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 242 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 243 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 244 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 245 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 246 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 247 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 248 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 249 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 250 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 251 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 252 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 253 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 254 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 255 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 256 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 257 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 258 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 259 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 260 Biologics Market Company Ranking for the Year 2021
Table 261 Biologics Market Recent Developments
Table 262 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 263 Johnson & Johnson Services Inc.: Product Benchmarking
Table 264 Johnson & Johnson Services inc.: Recent Developments
Table 265 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 266 Merck KGaA: Product Benchmarking
Table 267 Merck KGaA: Recent Developments
Table 268 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 269 GlaxoSmithKline plc.: Product Benchmarking
Table 270 GlaxoSmithKline plc.: Recent Developments
Table 271 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 272 Novartis AG: Product Benchmarking
Table 273 Novartis AG: Recent Developments
Table 274 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 275 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 276 F. Hoffmann-La Roche Ltd: Recent Developments
Table 277 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 278 Pfizer Inc.: Product Benchmarking
Table 279 Pfizer Inc.: Recent Developments
Table 280 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 281 Sanofi: Product Benchmarking
Table 282 Sanofi: Recent Developments
Table 283 Novo Holdings A/S (Novo Nordisk A/S): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 284 Novo Holdings A/S (Novo Nordisk A/S): Product Benchmarking
Table 285 Novo Holdings A/S (Novo Nordisk A/S): Recent Developments
Table 286 Takeda Pharmaceutical Company Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 287 Takeda Pharmaceutical Company Limited: Product Benchmarking
Table 288 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 289 Eli Lilly and Company: Product Benchmarking
Table 290 Eli Lilly and Company: Recent Developments
Table 291 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 292 Amgen Inc.: Product Benchmarking
Table 293 Amgen Inc.: Recent Developments
Table 294 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 295 Bristol-Myers Squibb Company: Product Benchmarking
Table 296 Bristol-Myers Squibb Company: Recent Developments
Table 297 Biogen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 298 Biogen: Product Benchmarking
Table 299 Biogen: Recent Developments
Table 300 NuVasive, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 301 NuVasive, Inc.: Product Benchmarking
Table 302 ORTHOFIX INTERNATIONAL N. V. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 303 ORTHOFIX INTERNATIONAL N.V. : Product Benchmarking
Table 304 Organogenesis Holdings Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 305 Organogenesis Holdings Inc. : Product Benchmarking
Table 306 Abbvie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 307 AbbVie Inc.: Product Benchmarking
Table 308 AbbVie Inc. : Recent Developments
List of Figures
Figure 1 Global Biologics Market Segmentation
Figure 2 Global Biologics Market: Market Dynamics
Figure 3 Global Biologics Market: SWOT Analysis
Figure 4 Global Biologics Market: Porter’s Five Forces Analysis
Figure 5 Global Biologics Market: PEST Analysis
Figure 6 Global Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR %)
Figure 7 Global Biologics Market Share Forecast by Product Type, 2022, 2026, 2032 (%)
Figure 8 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 9 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 10 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 11 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 12 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 13 Global Biologics Market for Vaccine Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 14 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 15 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 16 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 17 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 18 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 19 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 20 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 21 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 22 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 23 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 24 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 25 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 26 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 27 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 28 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 29 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 30 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 31 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 32 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 33 Global Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR %)
Figure 34 Global Biologics Market Share Forecast by Application, 2022, 2026, 2032 (%)
Figure 35 Global Biologics Market for Oncology Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 36 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 37 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 38 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 39 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 40 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 41 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 42 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 43 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 44 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 45 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 46 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 47 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 48 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 49 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 50 Global Biologics Market for Cardiovascular Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 51 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 52 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 53 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 54 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 55 Global Biologics Market for Haematological Disorders Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 56 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 57 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 58 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 59 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 60 Global Biologics Market for Others Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 61 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 62 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 63 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 64 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 65 Global Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 66 Global Biologics Market Share Forecast by Manufacturing, 2022, 2026, 2032 (%)
Figure 67 Global Biologics Market for In-house Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 68 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 69 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 70 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 71 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 72 Global Biologics Market for Outsourced Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 73 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 74 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 75 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 76 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 77 Global Biologics Market Forecast by Region 2022-2032 (US$ billion)
Figure 78 Global Biologics Market Share Forecast by Region 2022, 2026, 2032 (%)
Figure 79 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 80 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 81 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 82 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 83 North America Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 84 North America Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 85 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR %)
Figure 86 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 87 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 88 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 89 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 90 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 91 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 92 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 93 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 94 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 95 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 96 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 97 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 98 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 99 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 100 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 101 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 102 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 103 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 104 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 105 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 106 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 107 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 108 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 109 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 110 Europe Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 111 Europe Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 112 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 113 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 114 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 115 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 116 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 117 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 118 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 119 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 120 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 121 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 122 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
Figure 123 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 124 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 125 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 126 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 127 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 128 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 129 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 130 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 131 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 132 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 133 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 134 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 135 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 136 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 137 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 138 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 139 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 140 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 141 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 142 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 143 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 144 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 145 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 146 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 147 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 148 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 149 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 150 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 151 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 152 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 153 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 154 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 155 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 156 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 157 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 158 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 159 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 160 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 161 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 162 Asia Pacific Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 163 Asia Pacific Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 164 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 165 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 166 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 167 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 168 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 169 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 170 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 171 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 172 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 173 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 174 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
Figure 175 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 176 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 177 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 178 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 179 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 180 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 181 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 182 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 183 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 184 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 185 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 186 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 187 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 188 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 189 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 190 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 191 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 192 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 193 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 194 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 195 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 196 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 197 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 198 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 199 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 200 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 201 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 202 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 203 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 204 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 205 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 206 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 207 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 208 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 209 Latin America Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 210 Latin America Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 211 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 212 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 213 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 214 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 215 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 216 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 217 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 218 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 219 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 220 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 221 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
Figure 222 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 223 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 224 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 225 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 226 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 227 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 228 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 229 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 230 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 231 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 232 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 233 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 234 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 235 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 236 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 237 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 238 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 239 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 240 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 241 MEA Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 242 MEA Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 243 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 244 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 245 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 246 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 247 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 248 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 249 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 250 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 251 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 252 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 253 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 254 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 255 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 256 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 257 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 258 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 259 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 260 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 261 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 262 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 263 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 264 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 265 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 266 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 267 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 268 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 269 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 270 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 271 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 272 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 273 Johnson & Johnson Services Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 274 Johnson & Johnson Services Inc.: Regional Revenue Shares, 2021
Figure 275 Johnson & Johnson Services Inc.: Segmental Revenue Shares, 2021
Figure 276 Merck KGaA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 277 Merck KGaA: Regional Revenue Shares, 2021
Figure 278 Merck KGaA: Segmental Revenue Shares, 2021
Figure 279 GlaxoSmithKline plc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 280 GlaxoSmithKline plc.: Regional Revenue Shares, 2021
Figure 281 GlaxoSmithKline plc.: Segmental Revenue Shares, 2021
Figure 282 Novartis AG: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 283 Novartis AG: Regional Revenue Shares, 2021
Figure 284 Novartis AG: Segmental Revenue Shares, 2021
Figure 285 F. Hoffmann-La Roche Ltd. : Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 286 F. Hoffmann-La Roche Ltd: Segmental Revenue Shares, 2021
Figure 287 F. Hoffmann-La Roche Ltd: Regional Revenue Shares, 2021
Figure 288 Pfizer Inc.: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 289 Pfizer Inc.: Regional Revenue Shares, 2021
Figure 290 Pfizer Inc.: Segmental Revenue Shares, 2021
Figure 291 Sanofi: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 292 Sanofi: Regional Revenue Shares, 2021
Figure 293 Sanofi: Segmental Revenue Shares, 2021
Figure 294 Novo Holdings A/S (Novo Nordisk A/S): Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 295 Novo Holdings A/S (Novo Nordisk A/S): Regional Revenue Shares, 2020
Figure 296 Novo Holdings A/S (Novo Nordisk A/S): Segmental Revenue Shares, 2020
Figure 297 Takeda Pharmaceutical Company Limited: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 298 Takeda Pharmaceutical Company Limited: Regional Revenue Shares, 2020
Figure 299 Takeda Pharmaceutical Company Limited: Segmental Revenue Shares, 2020
Figure 300 Eli Lilly and Company: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 301 Eli Lilly and Company: Regional Revenue Shares, 2020
Figure 302 Amgen Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 303 Amgen Inc.: Regional Revenue Shares, 2021
Figure 304 Amgen Inc.: Segment Revenue Shares, 2021
Figure 305 Bristol-Myers Squibb Company: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 306 Bristol-Myers Squibb Company: Regional Revenue Shares, 2021
Figure 307 Biogen: Net Revenue, 2017-2021 (US $ million, AGR %)
Figure 308 Biogen: Regional Revenue Shares, 2021
Figure 309 NuVasive, Inc.: Net Revenue, 2017-2021 (US $ million, AGR %)
Figure 310 NuVasive Inc.: Regional Revenue Shares, 2021
Figure 311 NuVasive Inc.: Segment Revenue Shares, 2021
Figure 312 ORTHOFIX INTERNATIONAL N.V. : Net Revenue, 2017-2021 (US $ million, AGR %)
Figure 313 ORTHOFIX INTERNATIONAL N.V. : Regional Revenue Shares, 2021
Figure 314 ORTHOFIX INTERNATIONAL N.V. : Segment Revenue Shares, 2020
Figure 315 Organogenesis Holdings Inc. : Net Revenue, 2018-2021 (US $ million, AGR %)
Figure 316 Organogenesis Holdings Inc. : Segment Revenue Shares, 2021
Figure 317 AbbVie Inc. : Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 318 AbbVie Inc. : Regional Revenue Shares, 2021
Figure 319 AbbVie Inc. : Segment Revenue Shares, 2021
Figure 320 Global Biologics Market Share Forecast by Region, 2022, 2026, 2032 (%)
1.1 Introduction to Biologics Market
1.2 Biologics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Advancements in Biomedical Science
3.1.2 Increasing Funding for the Development of Novel Biologic Drugs
3.1.3 Several Drugs Going Off Patents
3.2 Restraints
3.2.1 High Stringency and Low Turnover for Clinical Trials
3.2.2 Development of Biosimilars will Reduce the Demand for Biological Drugs
3.3 Opportunities
3.3.1 Biologic Therapies are Becoming Relevant in a Greater Number of Disease Areas
3.4 Challenges
3.4.1 Complexity in Development of Biologics
3.5 SWOT Analysis
3.5.1 Strengths
3.5.1.1 Rising Need for Effective biologics Absorption and Convenient Self-Administration Emphasizes the Importance of the R&D Investment
3.5.2 Weaknesses
3.5.2.1 Financial Loss Due To Innovative Biologics Failure Has Been a Perennial Problem
3.5.3 Opportunities
3.5.3.1 Strong pipeline products and huge number of ongoing clinical trials are providing market growth opportunity.
3.5.3.2 Application of Nanotechnology in future
3.5.4 Threats
3.5.4.1 Small Molecules
3.6 Porter’s Five Forces Analysis
3.6.1 Bargaining Power of Supplier: High
3.6.2 Bargaining Power of Buyers: Moderate
3.6.3 Competitive Rivalry: High
3.6.4 Threat of New Entrants: Moderate
3.6.5 Threat of Substitutes: Low
3.7 PEST Analysis
3.7.1 Political Factors Impacting Biologics Market
3.7.2 Economic Factors Impacting Biologics Market
3.7.3 Social Factors Impacting Biologics Market
3.7.4 Technological Factors Impacting Biologics Market
4 Biologics Market by Product Type Forecast, 2022-2032
4.1 Monoclonal Antibodies Segment Market Forecast, 2022-2032
4.1.1 Monoclonal Antibodies: Holds Largest Market Share
4.1.2 Recovery Scenarios (V, U, W, L)
4.2 Vaccine Segment Market Forecast, 2022-2032
4.2.1 Vaccine Manufacturing Remains Concentrated, With Four Large Manufacturers
4.2.2 Recovery Scenarios (V, U, W, L)
4.3 Protein Therapeutics Segment Market Forecast, 2022-2032
4.3.1 Increased public knowledge of the benefits of protein therapies
4.3.2 Recovery Scenarios (V, U, W, L)
4.4 Regenerative Medicines Segment Market Forecast, 2022-2032
4.4.1 Government policies favouring Regenerative Medicines
4.4.2 Recovery Scenarios (V, U, W, L)
4.5 Fusion Proteins Segment Market Forecast, 2022-2032
4.5.1 Rising prevalence of diabetes expected to boost demand of fusion proteins
4.5.2 Recovery Scenarios (V, U, W, L)
5 Biologics Market by Application Forecast, 2022-2032
5.1 Oncology Segment Market Forecast, 2022-2032
5.1.1 Biological cancer therapy aims to train the immune system to recognise and kill cancer cells
5.1.2 Recovery Scenarios (V, U, W, L)
5.2 Autoimmune Diseases Segment Market Forecast, 2022-2032
5.2.1 Increasing Research and Development in this segment
5.2.2 Recovery Scenarios (V, U, W, L)
5.3 Infectious Diseases Therapeutics Segment Market Forecast, 2022-2032
5.3.1 Possible alternative to oral and parenteral routes of administration
5.3.2 Recovery Scenarios (V, U, W, L)
5.4 Cardiovascular Diseases Segment Market Forecast, 2022-2032
5.4.1 Cardiovascular Disorders is becoming the top cause of death worldwide
5.4.2 Recovery Scenarios (V, U, W, L)
5.5 Haematological Disorders Segment Market Forecast, 2022-2032
5.5.1 Blood disorders became a worldwide health issue
5.5.2 Recovery Scenarios (V, U, W, L)
5.6 Others Segment Market Forecast, 2022-2032
5.6.1 Adoption Haematological Disorders Technologies is expected to boost the Others Segment Growth
5.6.2 Recovery Scenarios (V, U, W, L)
6 Biologics Market by Manufacturing Forecast, 2022-2032
6.1 In-house Segment Market Forecast, 2022-2032
6.1.1 In-house holds largest Revenue market share
6.1.2 Recovery Scenarios (V, U, W, L)
6.2 Outsourced Segment Market Forecast, 2022-2032
6.2.1 Ease of use of Topical drug delivery to boost the outsourced market
6.2.2 Recovery Scenarios (V, U, W, L)
7 Global Biologics Market Forecast, 2022-2032
7.1 Global Biologics Market by Region Forecast 2022-2032
7.2 Recovery Scenarios (V, U, W, L)
8 North America Biologics Market, 2022-2032
8.1 Largest share acquired by North America in Global Biologics Market
8.2 North America Biologics Market by Country, Forecast 2022-2032
8.3 North America Biologics Market Forecast by Product Type
8.3.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Product Type, 2022-2032
8.4 North America Biologics Market Forecast by Application
8.4.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Application, 2022-2032
8.5 North America Biologics Market Forecast by Manufacturing
8.5.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Manufacturing, 2022-2032
8.6 U.S. Biologics Market Forecast, 2022-2032
8.6.1 Growing public and private funding for research studies in this region
8.6.2 Budget request for Pandemic preparedness
8.6.3 Recovery Scenarios (V, U, W, L): U.S. Biologics Market Forecast, 2022-2032
8.7 Canada Biologics Market Forecast, 2022-2032
8.7.1 Growing Prevalence of Psoriasis and Related Research and Development across the Region
8.7.2 Biologics represent a large segment of drug spending in Canada
8.7.3 Recovery Scenarios (V, U, W, L): Canada Biologics Market Forecast, 2022-2032
9 Europe Biologics Market, 2022-2032
9.1 Launch of Advanced Biologics across the Region
9.2 Europe Biologics Market by Country, Forecast 2022-2032
9.3 Europe Biologics Market Forecast by Product Type
9.3.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Product Type, 2022-2032
9.4 Europe Biologics Market Forecast by Application
9.4.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Application, 2022-2032
9.5 Europe Biologics Market Forecast by Manufacturing
9.5.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Manufacturing, 2022-2032
9.6 Germany Biologics Market Forecast, 2022-2032
9.6.1 German government support market player for product development
9.6.2 Recovery Scenarios (V, U, W, L): Germany Biologics Market Forecast, 2022-2032
9.7 U.K. Biologics Market Forecast, 2022-2032
9.7.1 Increase in prevalence of diabetes and skin conditions
9.7.2 Recovery Scenarios (V, U, W, L): U.K. Biologics Market Forecast, 2022-2032
9.8 France Biologics Market Forecast, 2022-2032
9.8.1 Growing cancer prevalence and French government cancer control strategy
9.8.2 Recovery Scenarios (V, U, W, L): France Biologics Market Forecast, 2022-2032
9.9 Italy Biologics Market Forecast, 2022-2032
9.9.1 Rising prevalence of cancer
9.9.2 Recovery Scenarios (V, U, W, L): Italy Biologics Market Forecast, 2022-2032
9.10 Spain Biologics Market Forecast, 2022-2032
9.10.1 Growing burden of Infectious diseases
9.10.2 Recovery Scenarios (V, U, W, L): Spain Biologics Market Forecast, 2022-2032
9.11 Russia Biologics Market Forecast, 2022-2032
9.11.1 Major leap forward in terms of Digitalization
9.11.2 Recovery Scenarios (V, U, W, L): Russia Biologics Market Forecast, 2022-2032
9.12 Rest of Europe Biologics Market Forecast, 2022-2032
9.12.1 Rising Adoption of Advanced Biologics
9.12.2 Recovery Scenarios (V, U, W, L): Rest of Europe Biologics Market Forecast, 2022-2032
10 Asia Pacific Biologics Market, 2022-2032
10.1 Biologics APAC will emerge as the fastest growing regional market for biologics market R&D and production
10.2 Asia Pacific Biologics Market by Country, Forecast 2022-2032
10.3 Asia Pacific Biologics Market Forecast by Product Type
10.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Product Type, 2022-2032
10.4 Asia Pacific Biologics Market Forecast by Application
10.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Application, 2022-2032
10.5 Asia Pacific Biologics Market Forecast by Manufacturing
10.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032
10.6 Japan Biologics Market Forecast, 2022-2032
10.6.1 Major market players investing on R&D
10.6.2 Recovery Scenarios (V, U, W, L): Japan Biologics Market Forecast, 2022-2032
10.7 China Biologics Market Forecast, 2022-2032
10.7.1 Rapid growth of Domestic mAb pipeline and regulatory reform is creating business opportunities for Biologics CDMO’s in China
10.7.2 Recovery Scenarios (V, U, W, L): China Biologics Market Forecast, 2022-2032
10.8 India Biologics Market Forecast, 2022-2032
10.8.1 India Biologics market currently is dominated by Simple Biologics
10.8.2 Recovery Scenarios (V, U, W, L): India Biologics Market Forecast, 2022-2032
10.9 Australia Biologics Market Forecast, 2022-2032
10.9.1 Growing capital investment by the market player
10.9.2 Recovery Scenarios (V, U, W, L): Australia Biologics Market Forecast, 2022-2032
10.10 South Korea Biologics Market Forecast, 2022-2032
10.10.1 Increasing prevalence of Cancer in South Korea
10.10.2 Recovery Scenarios (V, U, W, L): South Korea Biologics Market Forecast, 2022-2032
10.11 Rest of Asia Pacific Biologics Market Forecast, 2022-2032
10.11.1 Rising Disposable Income in this region
10.11.2 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Biologics Market Forecast, 2022-2032
11 Latin America Biologics Market, 2022-2032
11.1 Latin America Biologics Market expected to grow at lucrative CAGR
11.2 Latin America Biologics Market by Country, Forecast 2022-2032
11.3 Latin America Biologics Market Forecast by Product Type
11.3.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Product Type, 2022-2032
11.4 Latin America Biologics Market Forecast by Application
11.4.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Application, 2022-2032
11.5 Latin America Biologics Market Forecast by Manufacturing
11.5.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Manufacturing, 2022-2032
11.6 Brazil Biologics Market Forecast, 2022-2032
11.6.1 High Potential Manufacturing Environment
11.6.2 Recovery Scenarios (V, U, W, L): Brazil Biologics Market Forecast, 2022-2032
11.7 Mexico Biologics Market Forecast, 2022-2032
11.7.1 Lower Manufacturing Cost in Mexico
11.7.2 Recovery Scenarios (V, U, W, L): Mexico Biologics Market Forecast, 2022-2032
11.8 Rest of Latin America Biologics Market Forecast, 2022-2032
11.8.1 Developing Healthcare Infrastructure in this region
11.8.2 Recovery Scenarios (V, U, W, L): Rest of Latin America Biologics Market Forecast, 2022-2032
12 MEA Biologics Market, 2022-2032
12.1 Increasing occurrence of Cancer in this region
12.2 MEA Biologics Market by Country, Forecast 2022-2032
12.3 MEA Biologics Market Forecast by Product Type
12.3.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Product Type, 2022-2032
12.4 MEA Biologics Market Forecast by Application
12.4.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Application, 2022-2032
12.5 MEA Biologics Market Forecast by Manufacturing
12.5.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Manufacturing, 2022-2032
12.6 GCC Biologics Market Forecast, 2022-2032
12.6.1 Presence of Hug Growth Opportunities
12.6.2 Recovery Scenarios (V, U, W, L): GCC Biologics Market Forecast, 2022-2032
12.7 South Africa Biologics Market Forecast, 2022-2032
12.7.1 Rapidly increasing infectious diseases in this South Africa
12.7.2 Recovery Scenarios (V, U, W, L): South Africa Biologics Market Forecast, 2022-2032
12.8 Rest of MEA Biologics Market Forecast, 2022-2032
12.8.1 Cancer is one of the main reason of Death causes in Rest of MEA
12.8.2 Recovery Scenarios (V, U, W, L): Rest of MEA Biologics Market Forecast, 2022-2032
13 Company Profiles
13.1 Company Share Analysis
13.2 Biologics Market Recent Developments
13.3 Johnson & Johnson Services, Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2021
13.3.3.2 Regional Revenue/Market Shares, 2021
13.3.3.3 Segmental Revenue/Market Shares, 2021
13.3.4 Product Benchmarking
13.3.5 Recent Developments
13.4 Merck KGaA
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2021
13.4.3.2 Regional Revenue/Market Shares, 2021
13.4.3.3 Segmental Revenue/Market Shares, 2021
13.4.4 Product Benchmarking
13.4.5 Recent Developments
13.5 GlaxoSmithKline plc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2017-2021
13.5.3.2 Regional Revenue/Market Shares, 2021
13.5.3.3 Segmental Revenue/Market Shares, 2021
13.5.4 Product Benchmarking
13.5.5 Recent Developments
13.6 Novartis AG
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2017-2021
13.6.3.2 Regional Revenue/Market Shares, 2021
13.6.3.3 Segmental Revenue/Market Shares, 2021
13.6.4 Product Benchmarking
13.6.5 Recent Developments
13.7 F. Hoffmann-La Roche Ltd
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2017-2021
13.7.3.2 Segmental Revenue/Market Shares, 2021
13.7.3.3 Regional Revenue/Market Shares, 2020
13.7.4 Product Benchmarking
13.7.5 Recent Developments
13.8 Pfizer Inc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2017-2021
13.8.3.2 Regional Revenue/Market Shares, 2021
13.8.3.3 Segmental Revenue/Market Shares, 2021
13.8.4 Product Benchmarking
13.8.5 Recent Developments
13.9 Sanofi
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2017-2021
13.9.3.2 Regional Revenue/Market Shares, 2021
13.9.3.3 Segmental Revenue/Market Shares, 2021
13.9.4 Product Benchmarking
13.9.5 Recent Developments
13.10 Novo Holdings A/S (Novo Nordisk A/S)
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2017-2021
13.10.3.2 Regional Revenue/Market Shares, 2020
13.10.3.3 Segmental Revenue/Market Shares, 2020
13.10.4 Product Benchmarking
13.10.5 Recent Developments
13.11 Takeda Pharmaceutical Company Limited
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2017-2021
13.11.3.2 Regional Revenue/Market Shares, 2020
13.11.3.3 Segmental Revenue/Market Shares, 2020
13.11.4 Product Benchmarking
13.12 Eli Lilly and Company
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2017-2021
13.12.3.2 Regional Revenue/Market Shares, 2020
13.12.4 Product Benchmarking
13.12.5 Recent Developments
13.13 Amgen Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2017-2021
13.13.3.2 Regional Revenue Shares, 2021
13.13.3.3 Segment Revenue Shares, 2021
13.13.4 Product Benchmarking
13.13.5 Recent Developments
13.14 Bristol-Myers Squibb Company
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2017-2021
13.14.3.2 Regional Revenue Shares, 2021
13.14.4 Product Benchmarking
13.14.5 Recent Developments
13.15 Biogen
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis
13.15.3.1 Net Revenue, 2017-2021
13.15.3.2 Regional Revenue Shares, 2021
13.15.4 Product Benchmarking
13.15.5 Recent Developments
13.16 NuVasive, Inc.
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Financial Analysis
13.16.3.1 Net Revenue, 2017-2021
13.16.3.2 Regional Revenue Shares, 2021
13.16.3.3 Segment Revenue Shares, 2021
13.16.4 Product Benchmarking
13.17 ORTHOFIX INTERNATIONAL N.V.
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Financial Analysis
13.17.3.1 Net Revenue, 2017-2021
13.17.3.2 Regional Revenue Shares, 2021
13.17.3.3 Segment Revenue Shares, 2020
13.17.4 Product Benchmarking
13.18 Organogenesis Holdings Inc.
13.18.1 Company Snapshot
13.18.2 Company Overview
13.18.3 Financial Analysis
13.18.3.1 Net Revenue, 2018-2021
13.18.3.2 Segment Revenue Shares, 2021
13.18.4 Product Benchmarking
13.19 AbbVie Inc.
13.19.1 Company Snapshot
13.19.2 Company Overview
13.19.3 Financial Analysis
13.19.3.1 Net Revenue, 2017-2021
13.19.3.2 Regional Revenue Shares, 2021
13.19.3.3 Segment Revenue Shares, 2021
13.19.4 Product Benchmarking
13.19.5 Recent Developments
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
List of Tables
Table 1 Global Biologics Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 Global Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 3 Global Biologics examples of US FDA-approved monoclonal antibody present in the market, CAGR%)
Table 4 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 5 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 6 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 7 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 8 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 9 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 10 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 11 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 12 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 13 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 14 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 15 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 18 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 19 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 20 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 25 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 30 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 31 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 32 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 33 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 34 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 35 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 36 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global Biologics Market for Autoimmune diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 39 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 40 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 41 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 42 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 43 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 44 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 45 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 46 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 47 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 48 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 49 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 50 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 51 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 56 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 1 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Global Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 60 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 61 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 62 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 63 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 64 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 65 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 66 Global Biologics Market for outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 67 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 68 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 69 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 70 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 71 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 72 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 73 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 74 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 75 North America Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 76 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 77 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 78 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 79 North America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 80 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 81 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 82 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 84 North America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 85 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 86 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 87 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 88 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 89 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 90 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 91 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 92 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 93 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 94 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 95 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 96 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 97 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 101 Europe Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 102 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 103 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 104 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 105 Europe Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 106 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 107 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 108 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 109 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 110 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 111 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 112 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 113 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 114 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 115 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 116 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 117 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 118 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 119 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 120 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 121 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 122 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 123 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 124 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 125 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 126 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 127 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 128 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 129 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 130 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 131 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 132 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 133 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 134 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 135 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 136 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 137 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 138 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 139 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 140 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 141 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 142 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 143 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 144 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 145 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 146 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 147 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 148 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 149 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 150 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 151 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 152 Asia Pacific Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 153 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 154 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Asia Pacific Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 158 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 159 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Asia Pacific Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 162 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 163 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 164 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 165 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 166 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 167 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 168 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 169 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 170 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 171 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 172 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 173 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 174 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 175 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 176 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 177 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 178 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 179 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 180 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 181 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 182 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 183 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 184 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 185 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 186 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 187 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 188 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 189 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 190 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 191 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 192 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 193 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 194 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 195 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 196 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 197 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 198 Latin America Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 199 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 200 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 201 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 202 Latin America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 203 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 204 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 205 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 206 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 207 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 208 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 209 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 210 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 211 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 212 Latin America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 213 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 214 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 215 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 216 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 217 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 218 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 219 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 220 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 221 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 222 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 223 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 224 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 225 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 226 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 227 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 228 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 229 MEA Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 230 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 231 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 232 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 233 MEA Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 234 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 235 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 236 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 237 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 238 MEA Biologics Market Forecast by application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 239 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 240 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 241 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 242 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 243 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 244 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 245 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 246 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 247 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 248 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 249 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 250 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 251 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 252 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 253 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 254 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 255 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 256 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 257 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 258 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 259 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 260 Biologics Market Company Ranking for the Year 2021
Table 261 Biologics Market Recent Developments
Table 262 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 263 Johnson & Johnson Services Inc.: Product Benchmarking
Table 264 Johnson & Johnson Services inc.: Recent Developments
Table 265 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 266 Merck KGaA: Product Benchmarking
Table 267 Merck KGaA: Recent Developments
Table 268 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 269 GlaxoSmithKline plc.: Product Benchmarking
Table 270 GlaxoSmithKline plc.: Recent Developments
Table 271 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 272 Novartis AG: Product Benchmarking
Table 273 Novartis AG: Recent Developments
Table 274 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 275 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 276 F. Hoffmann-La Roche Ltd: Recent Developments
Table 277 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 278 Pfizer Inc.: Product Benchmarking
Table 279 Pfizer Inc.: Recent Developments
Table 280 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 281 Sanofi: Product Benchmarking
Table 282 Sanofi: Recent Developments
Table 283 Novo Holdings A/S (Novo Nordisk A/S): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 284 Novo Holdings A/S (Novo Nordisk A/S): Product Benchmarking
Table 285 Novo Holdings A/S (Novo Nordisk A/S): Recent Developments
Table 286 Takeda Pharmaceutical Company Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 287 Takeda Pharmaceutical Company Limited: Product Benchmarking
Table 288 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 289 Eli Lilly and Company: Product Benchmarking
Table 290 Eli Lilly and Company: Recent Developments
Table 291 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 292 Amgen Inc.: Product Benchmarking
Table 293 Amgen Inc.: Recent Developments
Table 294 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 295 Bristol-Myers Squibb Company: Product Benchmarking
Table 296 Bristol-Myers Squibb Company: Recent Developments
Table 297 Biogen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 298 Biogen: Product Benchmarking
Table 299 Biogen: Recent Developments
Table 300 NuVasive, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 301 NuVasive, Inc.: Product Benchmarking
Table 302 ORTHOFIX INTERNATIONAL N. V. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 303 ORTHOFIX INTERNATIONAL N.V. : Product Benchmarking
Table 304 Organogenesis Holdings Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 305 Organogenesis Holdings Inc. : Product Benchmarking
Table 306 Abbvie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 307 AbbVie Inc.: Product Benchmarking
Table 308 AbbVie Inc. : Recent Developments
List of Figures
Figure 1 Global Biologics Market Segmentation
Figure 2 Global Biologics Market: Market Dynamics
Figure 3 Global Biologics Market: SWOT Analysis
Figure 4 Global Biologics Market: Porter’s Five Forces Analysis
Figure 5 Global Biologics Market: PEST Analysis
Figure 6 Global Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR %)
Figure 7 Global Biologics Market Share Forecast by Product Type, 2022, 2026, 2032 (%)
Figure 8 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 9 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 10 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 11 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 12 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 13 Global Biologics Market for Vaccine Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 14 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 15 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 16 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 17 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 18 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 19 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 20 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 21 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 22 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 23 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 24 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 25 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 26 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 27 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 28 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 29 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 30 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 31 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 32 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 33 Global Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR %)
Figure 34 Global Biologics Market Share Forecast by Application, 2022, 2026, 2032 (%)
Figure 35 Global Biologics Market for Oncology Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 36 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 37 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 38 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 39 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 40 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 41 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 42 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 43 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 44 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 45 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 46 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 47 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 48 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 49 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 50 Global Biologics Market for Cardiovascular Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 51 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 52 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 53 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 54 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 55 Global Biologics Market for Haematological Disorders Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 56 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 57 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 58 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 59 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 60 Global Biologics Market for Others Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 61 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 62 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 63 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 64 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 65 Global Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 66 Global Biologics Market Share Forecast by Manufacturing, 2022, 2026, 2032 (%)
Figure 67 Global Biologics Market for In-house Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 68 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 69 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 70 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 71 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 72 Global Biologics Market for Outsourced Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 73 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 74 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 75 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 76 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 77 Global Biologics Market Forecast by Region 2022-2032 (US$ billion)
Figure 78 Global Biologics Market Share Forecast by Region 2022, 2026, 2032 (%)
Figure 79 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 80 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 81 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 82 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 83 North America Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 84 North America Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 85 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR %)
Figure 86 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 87 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 88 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 89 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 90 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 91 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 92 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 93 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 94 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 95 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 96 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 97 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 98 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 99 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 100 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 101 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 102 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 103 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 104 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 105 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 106 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 107 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 108 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 109 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 110 Europe Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 111 Europe Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 112 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 113 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 114 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 115 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 116 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 117 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 118 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 119 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 120 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 121 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 122 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
Figure 123 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 124 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 125 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 126 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 127 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 128 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 129 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 130 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 131 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 132 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 133 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 134 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 135 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 136 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 137 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 138 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 139 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 140 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 141 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 142 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 143 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 144 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 145 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 146 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 147 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 148 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 149 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 150 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 151 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 152 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 153 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 154 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 155 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 156 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 157 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 158 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 159 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 160 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 161 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 162 Asia Pacific Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 163 Asia Pacific Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 164 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 165 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 166 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 167 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 168 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 169 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 170 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 171 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 172 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 173 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 174 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
Figure 175 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 176 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 177 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 178 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 179 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 180 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 181 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 182 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 183 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 184 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 185 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 186 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 187 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 188 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 189 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 190 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 191 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 192 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 193 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 194 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 195 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 196 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 197 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 198 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 199 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 200 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 201 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 202 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 203 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 204 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 205 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 206 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 207 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 208 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 209 Latin America Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 210 Latin America Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 211 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 212 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 213 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 214 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 215 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 216 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 217 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 218 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 219 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 220 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 221 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
Figure 222 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 223 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 224 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 225 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 226 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 227 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 228 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 229 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 230 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 231 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 232 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 233 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 234 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 235 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 236 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 237 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 238 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 239 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 240 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 241 MEA Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 242 MEA Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 243 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 244 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 245 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 246 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 247 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 248 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 249 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 250 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 251 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 252 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 253 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 254 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 255 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 256 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 257 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 258 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 259 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 260 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 261 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 262 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 263 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 264 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 265 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 266 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 267 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 268 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 269 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 270 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 271 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 272 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 273 Johnson & Johnson Services Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 274 Johnson & Johnson Services Inc.: Regional Revenue Shares, 2021
Figure 275 Johnson & Johnson Services Inc.: Segmental Revenue Shares, 2021
Figure 276 Merck KGaA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 277 Merck KGaA: Regional Revenue Shares, 2021
Figure 278 Merck KGaA: Segmental Revenue Shares, 2021
Figure 279 GlaxoSmithKline plc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 280 GlaxoSmithKline plc.: Regional Revenue Shares, 2021
Figure 281 GlaxoSmithKline plc.: Segmental Revenue Shares, 2021
Figure 282 Novartis AG: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 283 Novartis AG: Regional Revenue Shares, 2021
Figure 284 Novartis AG: Segmental Revenue Shares, 2021
Figure 285 F. Hoffmann-La Roche Ltd. : Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 286 F. Hoffmann-La Roche Ltd: Segmental Revenue Shares, 2021
Figure 287 F. Hoffmann-La Roche Ltd: Regional Revenue Shares, 2021
Figure 288 Pfizer Inc.: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 289 Pfizer Inc.: Regional Revenue Shares, 2021
Figure 290 Pfizer Inc.: Segmental Revenue Shares, 2021
Figure 291 Sanofi: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 292 Sanofi: Regional Revenue Shares, 2021
Figure 293 Sanofi: Segmental Revenue Shares, 2021
Figure 294 Novo Holdings A/S (Novo Nordisk A/S): Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 295 Novo Holdings A/S (Novo Nordisk A/S): Regional Revenue Shares, 2020
Figure 296 Novo Holdings A/S (Novo Nordisk A/S): Segmental Revenue Shares, 2020
Figure 297 Takeda Pharmaceutical Company Limited: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 298 Takeda Pharmaceutical Company Limited: Regional Revenue Shares, 2020
Figure 299 Takeda Pharmaceutical Company Limited: Segmental Revenue Shares, 2020
Figure 300 Eli Lilly and Company: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 301 Eli Lilly and Company: Regional Revenue Shares, 2020
Figure 302 Amgen Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 303 Amgen Inc.: Regional Revenue Shares, 2021
Figure 304 Amgen Inc.: Segment Revenue Shares, 2021
Figure 305 Bristol-Myers Squibb Company: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 306 Bristol-Myers Squibb Company: Regional Revenue Shares, 2021
Figure 307 Biogen: Net Revenue, 2017-2021 (US $ million, AGR %)
Figure 308 Biogen: Regional Revenue Shares, 2021
Figure 309 NuVasive, Inc.: Net Revenue, 2017-2021 (US $ million, AGR %)
Figure 310 NuVasive Inc.: Regional Revenue Shares, 2021
Figure 311 NuVasive Inc.: Segment Revenue Shares, 2021
Figure 312 ORTHOFIX INTERNATIONAL N.V. : Net Revenue, 2017-2021 (US $ million, AGR %)
Figure 313 ORTHOFIX INTERNATIONAL N.V. : Regional Revenue Shares, 2021
Figure 314 ORTHOFIX INTERNATIONAL N.V. : Segment Revenue Shares, 2020
Figure 315 Organogenesis Holdings Inc. : Net Revenue, 2018-2021 (US $ million, AGR %)
Figure 316 Organogenesis Holdings Inc. : Segment Revenue Shares, 2021
Figure 317 AbbVie Inc. : Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 318 AbbVie Inc. : Regional Revenue Shares, 2021
Figure 319 AbbVie Inc. : Segment Revenue Shares, 2021
Figure 320 Global Biologics Market Share Forecast by Region, 2022, 2026, 2032 (%)
List of Companies Profiled in the report
AbbVie Inc.
Amgen Inc.
Biogen
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
Merck KGaA
Novartis AG
NuVasive, Inc.
Novo Holdings A/S (Novo Nordisk A/S)
Organogenesis Holdings Inc.
ORTHOFIX INTERNATIONAL N.V.
Pfizer Inc.
Sanofi
Takeda Pharmaceutical Company Limited
List of Other Companies Mentioned in the report
Abz-Pharma GmbH
Accord Healthcare Ltd
Alexion Pharmaceuticals Inc
AstraZeneca
Berlex Inc.
Biocon
BioPartners GmbH
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Celltech, UCB.
Celltrion Healthcare Hungary Kft.
Centocor Ortho Biotech Products LP
Chugai Pharmaceutical Co., Ltd
Coherus Biosciences
Dyax Corp.
Genmab A/S
Genzyme Corp.
Guardant Health
Hexal Ag
Hospira UK Limited
Janssen Biotech Inc
Kyowa Hakko Kirin
Medarex
Medice Arzneimittel Putter GmbH & Co. Kg
MedImmune
Millennium Pharmaceuticals Inc
Mylan
NovImmmune
Qiagen
Ratiopharm GmbH
Regeneron Pharmaceuticals
Samsung Bioepis
Sandoz GmbH
Stada Arzneimittel Ag
Sysmex Inostics
Taimed Biologics
Teva GmbH
United Therapeutics Corporation
Wyeth Pharmaceuticals
List of Organizations
Centers for Disease Control and Prevention (CDC)
Central Drug Standard Control Organization (CDSCO)
Centre for Pharmaceutical Administration Health Sciences Authority
European Medicines Agency (EMA)
European Union
Food and Drug Administration (FDA)
French Government
Government of Japan
Health Ministry (Italy)
Indian Council of Medical Research (ICMR)
Institute for Healthcare Improvement (IHI)
Italian Industry Group Farmindustria
Japanese Ministry of Health, Labour and Welfare
Medicines and Healthcare Products Regulatory Agency (MHRA)
Ministry of Health, Labour & Welfare(MHLW)
National Institute of Health (NIH)
NCBI
Organisation for Economic Co-operation and Development (OECD)
Pharmaceuticals and Medical Devices Agency (PMDA)
Statistical Office of the European Union (EUROSTAT)
United Nations (UN)
United Nations Statistics Division (UNSD)
World Health Organization (WHO)
AbbVie Inc.
Amgen Inc.
Biogen
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
Merck KGaA
Novartis AG
NuVasive, Inc.
Novo Holdings A/S (Novo Nordisk A/S)
Organogenesis Holdings Inc.
ORTHOFIX INTERNATIONAL N.V.
Pfizer Inc.
Sanofi
Takeda Pharmaceutical Company Limited
List of Other Companies Mentioned in the report
Abz-Pharma GmbH
Accord Healthcare Ltd
Alexion Pharmaceuticals Inc
AstraZeneca
Berlex Inc.
Biocon
BioPartners GmbH
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Celltech, UCB.
Celltrion Healthcare Hungary Kft.
Centocor Ortho Biotech Products LP
Chugai Pharmaceutical Co., Ltd
Coherus Biosciences
Dyax Corp.
Genmab A/S
Genzyme Corp.
Guardant Health
Hexal Ag
Hospira UK Limited
Janssen Biotech Inc
Kyowa Hakko Kirin
Medarex
Medice Arzneimittel Putter GmbH & Co. Kg
MedImmune
Millennium Pharmaceuticals Inc
Mylan
NovImmmune
Qiagen
Ratiopharm GmbH
Regeneron Pharmaceuticals
Samsung Bioepis
Sandoz GmbH
Stada Arzneimittel Ag
Sysmex Inostics
Taimed Biologics
Teva GmbH
United Therapeutics Corporation
Wyeth Pharmaceuticals
List of Organizations
Centers for Disease Control and Prevention (CDC)
Central Drug Standard Control Organization (CDSCO)
Centre for Pharmaceutical Administration Health Sciences Authority
European Medicines Agency (EMA)
European Union
Food and Drug Administration (FDA)
French Government
Government of Japan
Health Ministry (Italy)
Indian Council of Medical Research (ICMR)
Institute for Healthcare Improvement (IHI)
Italian Industry Group Farmindustria
Japanese Ministry of Health, Labour and Welfare
Medicines and Healthcare Products Regulatory Agency (MHRA)
Ministry of Health, Labour & Welfare(MHLW)
National Institute of Health (NIH)
NCBI
Organisation for Economic Co-operation and Development (OECD)
Pharmaceuticals and Medical Devices Agency (PMDA)
Statistical Office of the European Union (EUROSTAT)
United Nations (UN)
United Nations Statistics Division (UNSD)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Biologics Market Report 2022-2032Related reports
-
3D Cell Culture and 3D Bioprinting Market Report 2022-2032
The 3D cell culture market is experiencing impressive growth globally because of the tremendous increase in demand for biopharmaceutical products....Full DetailsPublished: 15 February 2022 -
Cancer Diagnostics Market Report 2021-2031
Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel...Full DetailsPublished: 14 April 2021 -
Precision Medicine Market Report 2022-2032
The global precision medicine market was valued at US$63,333 million in 2021 and is projected to grow at a CAGR...Full DetailsPublished: 05 July 2022 -
Biobanking Market Report 2022-2032
The global biobanking market was valued at US$56,955 million in 2021 and is projected to grow at a CAGR of...Full DetailsPublished: 11 July 2022 -
Biosimilar Monoclonal Antibodies Market Report 2022-2032
The global biosimilar monoclonal antibodies market was valued at US$4,087 million in 2021 and is projected to grow at a...Full DetailsPublished: 25 July 2022 -
Synthetic Biology Market Report 2022-2032
The global synthetic biology market was valued at US$13.8 billion in 2021 and is projected to grow at a CAGR...Full DetailsPublished: 27 July 2022 -
Single-Cell Analysis Market Report 2022-2032
The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a...Full DetailsPublished: 26 May 2022 -
Cancer Biologics Market Report 2023-2033
The global Cancer Biologics market was estimated to be valued at US$ 115.9 billion in 2023 and is expected to...Full DetailsPublished: 22 June 2023 -
Liposomal Drug Delivery Devices Market Report 2022-2032
Global liposomal drug delivery devices market is projected to grow at a CAGR of 10.69% by 2032....Full DetailsPublished: 21 June 2022 -
Precision Cancer Diagnostic Test Market Report 2024-2034
The global Precision Cancer Diagnostic Test Market is projected to grow at a CAGR of 16.1% by 2034...Full DetailsPublished: 17 January 2024
Download sample pages
Complete the form below to download your free sample pages for Biologics Market Report 2022-2032Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Latest Pharma news
Pharmaceutical Contract Manufacturing Market
The global Pharmaceutical Contract Manufacturing market is projected to grow at a CAGR of 11.5% by 2034
30 July 2024
Retinal Gene Therapy Market
The global Retinal Gene Therapy market is projected to grow at a CAGR of 9.6% by 2034
26 July 2024
HIV Drugs and Injectables Market
The global HIV Drugs & Injectables market is projected to grow at a CAGR of 4.6 % by 2034
24 July 2024
Digital Twin Technology in Pharmaceutical Manufacturing Market
The global Digital Twin Technology in Pharmaceutical Manufacturing market is projected to grow at a CAGR of 31.3% by 2034
23 July 2024
